Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250925857310/en/Anebulo-Pharmaceuticals-Announces-First-Patients-Dosed-in-Phase-1-Single-Ascending-Dose-Study-of-Intravenous-Selonabant-under-Development-for-Acute-Cannabis-Induced-Toxicity

BUSINESSWIRE
25 Sep 2025

https://www.businesswire.com/news/home/20241223198725/en

BUSINESSWIRE
23 Dec 2024